Clearance-dependent underprediction of in vivo intrinsic clearance from human hepatocytes: comparison with permeabilities from artificial membrane (PAMPA) assay, in silico and caco-2 assay, for 65 drugs
Abstract
Underprediction of in vivo intrinsic clearance (CLint) from suspended human hepatocytes has recently been shown to be clearance-dependent although the mechanistic basis is currently unknown. One possible explanation is rate limiting transmembrane (passive) permeation into hepatocytes in vitro; evidence to support this has been minor to date, but there has not been a systematic exploration of the impact of passive permeability in vitro. To investigate the relationship between underprediction of in vivo CLint and potentially rate limiting permeability, permeability constants (Px, collated from published studies and determined experimentally in this study), using three alternative methodologies (parallel artificial membrane permeability assay (PAMPA), caco-2 permeability assay and calculated using an empirical model) were compared with CLint from suspended human hepatocytes for 65 drugs from a recently reported database of clearance predictions. Although there was an approximate correspondence between hepatocyte CLint and permeability measured by PAMPA (but not by caco-2 or modelling), prediction accuracy was not dependent on the relative permeability (measured as the ratio of CLint to permeability), indicating the absence of a general rate limitation by passive hepatocyte uptake on metabolic clearance. Further investigation into rate-dependent CLint in hepatocytes is required.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
De Buck 2007 investigated prediction of hepatic clearance using two methods; method 2 performed considerably better at predicting in vivo hepatic clearance from in vitro CLint, potentially through unintentionally compensating for inherent underprediction in CLint when scaling from HLMs or human hepatocytes.
“De Buck 2007 investigated the prediction of hepatic clearance using two different methods, method 1 using the traditional formula involving fu p /BP and fu inc , and method 2 where the effects of fu p /BP and fu inc were assumed to cancel each other out.The second method performed considerably better at predicting in vivo hepatic clearance from in vitro CL int , potentially through unintentionally”
From IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes (2017) · cites this paper as Hallifax et al., 2012
The citation lists haven’t been fetched yet
References 15 · Cited by 26
- Authors
- Hallifax, D., Turlizzi, E., Zanelli, U., & Houston, J. B.
- Affiliations
- University of Manchester (GB)
- Siena Biotech (Italy) (IT)
- Corresponding author
- Hallifax, David
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 45
- Issue
- 5
- Pages
- 570-574
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2158053130
- Cited by
- 26
- References
- 15
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 4 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- Sixth Framework Programme
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- intrinsic clearance, human hepatocytes, passive permeability, Pampas, Caco-2 permeability, drug clearance prediction, hepatocyte uptake
- MeSH terms
- Cell Membrane Permeability, Humans, Membranes, Artificial, Pharmacokinetics, Caco-2 Cells, Hepatocytes, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review